• Logo
  • SBMUJournals

The critical role of injecting drug users on the spatial distribution of hepatitis C virus; a study in the West of Iran

Farid Azizi Jalilian, Masoud Parvin, Meysam Olfatifar, Hossein Erfani, Jalal Bathaei
21

Views

PDF

Abstract

.


Keywords

Hepatitis C Virus, Spatial Analysis, Hamadan Province

References

Gao X, Cui Q, Shi X, Su J, Peng Z, Chen X, et al. Prevalence and trend of hepatitis C virus infection among blood donors in Chinese mainland: a systematic review and meta-analysis. BMC infectious diseases. 2011;11(1):88.

McHutchison JG, Bacon BR. Chronic hepatitis C: an age wave of disease burden. Am J Manag Care. 2005;11(10 Suppl):S286-95.

Poorolajal J, Mirzaei M, Bathaei SJ, Majzoobi MM. Hepatitis B and C infections in hamadan province during 2004-2009. Journal of research in health sciences. 2011;11(1):51-7.

Chen F, Sun D, Guo Y, Guo W, Ding Z, Li P, et al. Spatiotemporal Scan and Age-Period-Cohort Analysis of Hepatitis C Virus in Henan, China: 2005–2012. PloS one. 2015;10(6):e0129746.

Alavian SM, Hajarizadeh B, Lankarani KB, Sharafi H, Daryani NE, Merat S, et al. Recommendations for the clinical management of hepatitis C in Iran: a consensus-based national guideline. Hepatitis monthly. 2016;16(8).

Hajarizadeh B, Razavi-Shearer D, Merat S, Alavian SM, Malekzadeh R, Razavi H. Liver disease burden of hepatitis C virus infection in Iran and the potential impact of various treatment strategies on the disease burden. Hepatitis monthly. 2016;16(7).

Taherkhani R, Farshadpour F. Lurking epidemic of hepatitis C virus infection in Iran: A call to action. World journal of hepatology. 2017;9(24):1040-2.

Hepatitis C 2016 [updated July 2015. Available from: http://www.who.int/mediacentre/factsheets/fs164/en/.

Musa GJ, Chiang P-H, Sylk T, Bavley R, Keating W, Lakew B, et al. Use of GIS Mapping as a Public Health Tool—From Cholera to Cancer. Health Services Insights. 2013;6:111-6.

Lal A. Spatial Modelling Tools to Integrate Public Health and Environmental Science, Illustrated with Infectious Cryptosporidiosis. International Journal of Environmental Research and Public Health. 2016;13(2):186.

Iran's national port statistics 2016 [Available from: http://www.amar.org.ir/.

Xia X, Luo J, Bai J, Yu R. Epidemiology of hepatitis C virus infection among injection drug users in China: Systematic review and meta-analysis. Public Health. 2008;122(10):990-1003.

Reimer J, Haasen C. Need-adapted HCV-treatment setting for injection drug users. The Lancet. 2009;373(9681):2090-1.

Taherkhani R, Farshadpour F. Epidemiology of hepatitis C virus in Iran. World journal of gastroenterology: WJG. 2015;21(38):10790.

Dahari H, Boodram B. How to eliminate HCV in people who inject drugs in the USA. The Lancet Infectious Diseases. 2017.

Khan B, Duncan I, Saad M, Schaefer D, Jordan A, Smith D, et al. Combination interventions for Hepatitis C and Cirrhosis reduction among people who inject drugs: An agent-based, networked population simulation experiment. arXiv preprint arXiv:171003366. 2017.

Virlogeux V, Zoulim F, Pugliese P, Poizot-Martin I, Valantin M-A, Cuzin L, et al. Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination. BMC medicine. 2017;15(1):217.

WHO. #NOhep global movement to support WHO hepatitis strategy [4/February/2018]. Available from: http://www.who.int/hepatitis/news-events/nohep-movement-against-hepatitis/en/.

Keramat F, Eini P, Majzoobi MM. Seroprevalence of HIV, HBV and HCV in Persons Referred to Hamadan Behavioral Counseling Center, West of Iran. Iranian Red Crescent Medical Journal. 2011;13(1):42-6.

Zobeiri M, Adibi P, Alavian SM. Intravenous Drug Use and Hepatitis C Virus in Iran. Hepatitis Monthly. 2012;12(1):9-10.

Sofian M, Aghakhani A, Banifazl M, Azadmanesh K, Farazi AA, McFarland W, et al. Viral hepatitis and HIV infection among injection drug users in a central Iranian City. Journal of addiction medicine. 2012;6(4):292-6.




DOI: https://doi.org/10.22037/ghfbb.v0i0.1456